CYTENA is a leading provider of high-precision instruments for isolating, dispensing, imaging, analyzing and handling biological cells. The company continues to build on the success of the single-cell dispensing technology it patented as a spin-off from the University of Freiburg, Germany, in 2014. Today, as part of BICO, the world’s leading bio convergence company, CYTENA’s award-winning devices are still manufactured in Germany and used at prestigious academic and pharmaceutical labs around the world to automate workflows in numerous application areas, including stable cell line development, gene and cell therapy, high-throughput screening and microbiome research. CYTENA’s breakthrough innovations for the lab combine advanced automation, state-of-the-art software engineering and the latest insights in cell biology to maximize efficiencies in the life sciences and create the future of health. Learn more at www.cytena.com.
Accelerate Your Bacterial and Yeast Isolation Workflows with the B.SIGHT™ Microbial Isolation Platform
Single cell bacterial cloning, used to isolate and propagate individual bacterial cells, is an important research tool across a wide range of scientific disciplines. In microbiome research, the isolation and cultivation of new bacterial species ... Continued
Cell and gene therapy holds immense potential to revolutionize the field of medicine by addressing the root genetic causes of diseases or empowering cells to fight against them. This approach has already achieved remarkable successes ... Continued